Want to see HK:8329 full AI Analyst Report?
Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. Class H (8329) Ratios
Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. Class H Ratios
HK:8329's free cash flow for Q2 2026 was $-4.59M. For the 2026 fiscal year, HK:8329's free cash flow was decreased by $-3.31M and operating cash flow was $-1.28M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.01 | 2.38 | 2.51 | 2.17 | 2.21 |
| Quick Ratio | 1.52 | 1.77 | 1.95 | 1.68 | 1.73 |
| Cash Ratio | 0.61 | 0.83 | 1.02 | 0.70 | 0.68 |
| Solvency Ratio | -0.02 | 0.14 | 0.14 | 0.20 | 0.18 |
| Operating Cash Flow Ratio | 0.43 | 0.07 | 0.15 | 0.15 | -0.21 |
| Short-Term Operating Cash Flow Coverage | 1.99 | 0.25 | 0.63 | 0.72 | -0.69 |
| Net Current Asset Value | $ 300.05M | $ 437.04M | $ 521.12M | $ 452.16M | $ 376.81M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.07 | 0.08 | 0.06 | 0.06 | 0.08 |
| Debt-to-Equity Ratio | 0.11 | 0.11 | 0.10 | 0.10 | 0.13 |
| Debt-to-Capital Ratio | 0.10 | 0.10 | 0.09 | 0.09 | 0.11 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.63 | 1.50 | 1.56 | 1.64 | 1.58 |
| Debt Service Coverage Ratio | 0.66 | 0.45 | 0.59 | 1.16 | 0.65 |
| Interest Coverage Ratio | -10.73 | 6.84 | 6.50 | 12.70 | 9.51 |
| Debt to Market Cap | 0.30 | 0.40 | 0.35 | 0.35 | 0.40 |
| Interest Debt Per Share | 0.05 | 0.07 | 0.06 | 0.06 | 0.07 |
| Net Debt to EBITDA | -2.35 | -2.83 | -4.04 | -1.58 | -1.64 |
| Profitability Margins | |||||
| Gross Profit Margin | 29.55% | 31.49% | 41.25% | 45.01% | 44.60% |
| EBIT Margin | 2.12% | 3.33% | 3.40% | 9.05% | 5.21% |
| EBITDA Margin | 5.53% | 6.03% | 6.56% | 12.69% | 8.82% |
| Operating Profit Margin | -4.57% | 3.33% | 3.40% | 9.05% | 5.21% |
| Pretax Profit Margin | -5.00% | 2.85% | 2.88% | 8.34% | 4.66% |
| Net Profit Margin | -4.19% | 2.40% | 2.27% | 5.51% | 4.29% |
| Continuous Operations Profit Margin | -5.46% | 1.32% | 1.36% | 6.47% | 4.09% |
| Net Income Per EBT | 83.90% | 84.38% | 78.66% | 66.07% | 91.94% |
| EBT Per EBIT | 109.32% | 85.38% | 84.62% | 92.12% | 89.48% |
| Return on Assets (ROA) | -3.85% | 1.79% | 1.70% | 3.75% | 2.75% |
| Return on Equity (ROE) | -6.29% | 2.68% | 2.66% | 6.15% | 4.33% |
| Return on Capital Employed (ROCE) | -6.07% | 3.28% | 3.45% | 8.62% | 4.50% |
| Return on Invested Capital (ROIC) | -5.54% | 1.39% | 1.51% | 6.17% | 3.56% |
| Return on Tangible Assets | -4.35% | 2.06% | 1.96% | 4.38% | 3.31% |
| Earnings Yield | -17.00% | 9.74% | 9.68% | 21.32% | 14.22% |
| Efficiency Ratios | |||||
| Receivables Turnover | 3.42 | 3.53 | 3.92 | 3.66 | 3.73 |
| Payables Turnover | 4.81 | 4.98 | 4.19 | 4.76 | 4.83 |
| Inventory Turnover | 4.31 | 3.46 | 3.05 | 2.67 | 2.94 |
| Fixed Asset Turnover | 3.71 | 3.75 | 3.74 | 3.29 | 2.72 |
| Asset Turnover | 0.92 | 0.75 | 0.75 | 0.68 | 0.64 |
| Working Capital Turnover Ratio | 2.44 | 2.04 | 2.05 | 2.23 | 1.67 |
| Cash Conversion Cycle | 115.63 | 135.44 | 125.88 | 159.69 | 146.18 |
| Days of Sales Outstanding | 106.75 | 103.27 | 93.09 | 99.80 | 97.73 |
| Days of Inventory Outstanding | 84.77 | 105.46 | 119.85 | 136.58 | 124.06 |
| Days of Payables Outstanding | 75.89 | 73.29 | 87.06 | 76.70 | 75.62 |
| Operating Cycle | 191.51 | 208.73 | 212.94 | 236.39 | 221.80 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.08 | 0.01 | 0.03 | 0.04 | -0.04 |
| Free Cash Flow Per Share | 0.07 | 0.00 | 0.02 | 0.02 | -0.05 |
| Dividend Paid and CapEx Coverage Ratio | 0.54 | 1.10 | 3.49 | 3.11 | -4.64 |
| Capital Expenditure Coverage Ratio | 9.54 | 1.10 | 3.49 | 3.11 | -4.64 |
| Operating Cash Flow Coverage Ratio | 1.91 | 0.23 | 0.60 | 0.66 | -0.66 |
| Operating Cash Flow to Sales Ratio | 0.14 | 0.02 | 0.05 | 0.06 | -0.08 |
| Free Cash Flow Yield | 52.14% | 0.86% | 15.37% | 16.29% | -33.62% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -5.88 | 10.27 | 10.34 | 4.69 | 7.03 |
| Price-to-Sales (P/S) Ratio | 0.25 | 0.25 | 0.23 | 0.26 | 0.30 |
| Price-to-Book (P/B) Ratio | 0.37 | 0.28 | 0.27 | 0.29 | 0.30 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 1.92 | 116.66 | 6.51 | 6.14 | -2.97 |
| Price-to-Operating Cash Flow Ratio | 1.72 | 10.52 | 4.64 | 4.16 | -3.62 |
| Price-to-Earnings Growth (PEG) Ratio | 0.02 | 2.96 | -0.19 | 0.09 | -3.83 |
| Enterprise Value Multiple | 2.11 | 1.25 | -0.47 | 0.46 | 1.78 |
| Enterprise Value | 113.22M | 78.89M | -33.16M | 57.44M | 131.36M |
| EV to EBITDA | 2.11 | 1.25 | -0.47 | 0.46 | 1.78 |
| EV to Sales | 0.12 | 0.08 | -0.03 | 0.06 | 0.16 |
| EV to Free Cash Flow | 0.91 | 35.83 | -0.87 | 1.38 | -1.55 |
| EV to Operating Cash Flow | 0.81 | 3.23 | -0.62 | 0.94 | -1.88 |
| Tangible Book Value Per Share | 0.35 | 0.50 | 0.49 | 0.48 | 0.43 |
| Shareholders’ Equity Per Share | 0.39 | 0.56 | 0.54 | 0.53 | 0.49 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.09 | 0.54 | 0.53 | 0.22 | 0.12 |
| Revenue Per Share | 0.58 | 0.62 | 0.63 | 0.59 | 0.50 |
| Net Income Per Share | -0.02 | 0.01 | 0.01 | 0.03 | 0.02 |
| Tax Burden | 0.84 | 0.84 | 0.79 | 0.66 | 0.92 |
| Interest Burden | -2.36 | 0.85 | 0.85 | 0.92 | 0.89 |
| Research & Development to Revenue | 0.03 | 0.03 | 0.04 | 0.03 | 0.03 |
| SG&A to Revenue | 0.24 | 0.25 | 0.08 | 0.09 | 0.10 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | -2.87 | 0.82 | 1.75 | 0.74 | -1.79 |
Currency in CNY
